DNA Modifications and Alzheimer's Disease.

Area of Science:

• Neuroscience
• Genetics
• Epigenetics

Background:

• Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with complex etiology.
• Genetic factors for late-onset AD often have small effect sizes, prompting investigation into other mechanisms.
• Non-genetic risk factors like age and comorbidities require further understanding of their influence on AD risk.

Purpose of the Study:

• To review the current research on epigenetic mechanisms, specifically DNA modifications, in Alzheimer's disease.
• To discuss the role of 5-methylcytosine (5-mC) in AD pathogenesis.
• To highlight recent advancements and future directions in epigenetic research for AD.

Main Methods:

• Review of earlier studies on candidate genes and global DNA modifications in human AD samples and mouse models.
• Focus on recent epigenome-wide association studies (EWAS) in human AD.
• Utilized microarray technology for EWAS and examined critical study design considerations.

Main Results:

• DNA modifications, particularly 5-mC, are a significant area of investigation in AD.
• EWAS are providing new insights into the epigenetic landscape of AD.
• Technological advancements are crucial for further progress in the field.

Conclusions:

• Epigenetic modifications represent a promising avenue for understanding Alzheimer's disease etiology.
• Continued research, leveraging advanced technologies, is essential to elucidate the role of epigenetics in AD.
• Understanding epigenetic contributions can lead to novel diagnostic and therapeutic strategies for AD.